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Background: Periodontitis is characterized by extensive destruc-
tion of the gingival tissues and associated supporting structures of
the teeth. Although the pathogenesis of the various forms of this
disease is not completely understood, host-derived proteases are
believed to have an important role. In this study, we analyzed
human tissue samples from chronic adult periodontitis patients to
assess the levels of specific proteases and determine the effect of
pH and tetracyclines on their activity.
Methods: Gingival tissue samples were obtained from patients
with chronic adult periodontitis (probing depths ranged from 5 to
9 mm) and periodontally healthy controls. Tissue extracts were
prepared and analyzed for protease activity by zymography and
Western blotting.
Results: Maximal protease activity from clinically normal and
diseased tissues was observed at pH 8. Latent matrix metallopro-
teinase (MMP)-9 and MMP-2 were expressed in all samples exam-
ined, while active MMP-2 was detected only in tissues obtained
from patients with clinical disease. The MMP activities were dif-
ferentially inhibited by derivatives of tetracycline. At pH 6, a pro-
tease with a mass of approximately 40 kDa was observed in dis-
eased samples. The enzymatic activity was inhibited by
phenylmethylsulfonyl fluoride, suggesting it is a serine protease.
Conclusions: The results of the current study substantiate the
proposed role of host-derived proteases in the pathogenesis of
chronic adult periodontitis. Specifically, they indicate that activated
MMP-2 and a 40 kDa serine protease are involved in tissue destruc-
tion associated with this form of periodontal disease and also sug-
gest that tissue pH influences protease activity in situ. J Periodontol
2000;71:353-360.
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It is widely believed that destructionof the connective tissue attachmentof teeth and adjacent alveolar bone
observed in patients with chronic adult
periodontitis is a consequence of host
inflammatory reactions initiated in
response to bacterial colonization of
the subgingival environment.1 A vari-
ety of factors contribute to the patho-
genesis of periodontitis including inad-
equate oral hygiene, dietary and
genetic components, as well as com-
position of the oral microbiota.2 While
the specific precipitating factors are
not completely understood, the initial
response by the host involves activa-
tion and mobilization of inflammatory
cells such as macrophages, lympho-
cytes, and neutrophils.3 Among the
consequences of these events are
altered levels of specific immunomod-
ulators and the release of inflamma-
tory proteases.3,4 Many proteases are
capable of degrading a wide variety of
substrates including collagen, a major
constituent of the extracellular matrix
(ECM) within the periodontium. The
enhanced activity of these enzymes is
thought to be involved in the exten-
sive tissue destruction observed in
many chronic inflammatory diseases.
A number of studies have implicated
matrix metalloproteinases (MMPs) and
other proteases as playing a central
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role in the pathogenesis of periodontal disease (reviewed
in reference 5). As a group, the MMPs are capable of
degrading the majority of proteins found within the
ECM. Several reports have documented the presence
of specific MMPs including gelatinases A and B (MMP-
2 and MMP-9), interstitial collagenases (MMP-1 and
MMP-8), and stromelysin (MMP-3) in gingival biopsy
specimens and gingival crevicular fluid (GCF).5-7
Makela et al. detected increased levels of MMP-2 and
MMP-9 in periodontitis patients and found that latent
MMP-9 (92 kDa) was the major gelatinase in GCF and
saliva.8 Recent studies utilizing a quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) have
shown preferential expression of MMP-3, followed by
MMP-1 and MMP-8 in periodontitis-affected tissue.9
Lee and colleagues demonstrated an association
between increased GCF MMP-8 activity and progres-
sive loss of connective tissue attachment,10 while lon-
gitudinal studies have shown a significant decrease in
GCF MMP activity following successful periodontal
treatment.11,12 In addition, increases in the levels of
neutrophil-derived serine proteases, such as cathepsin
G and thiol proteases, have also been associated with
periodontal tissue breakdown.13,14 Taken together,
these results strongly suggest that host-derived pro-
teases play an important role in tissue destruction
observed in periodontal disease.
In situ, protease activity is controlled at multiple
levels. These include: 1) transcriptional regulation of
the genes encoding individual enzymes; 2) seques-
tration of proteolytic enzymes in intracellular vesicles;
3) regulation of processing and activation of latent
proenzymes; 4) presence of endogenous inhibitors
including the tissue inhibitors of metalloproteinases
(TIMPs) and serine protease inhibitors (serpins); and
5) effects of specific local environmental factors such
as tissue pH. With respect to chronic inflammatory
diseases in general, compounds that inhibit proteolytic
degradation of the ECM have potential therapeutic
value. It is well established that tetracycline (TC) and
its derivatives inhibit collagenases (MMP-1 and -8)
via a mechanism independent of their antimicrobial
activity (reviewed in reference 15). In clinical trials,
adult periodontitis patients treated with low-dose reg-
imens of doxycycline exhibited reduced levels of gin-
gival and GCF collagenase activity in association with
decreased attachment loss relative to controls.16-18
The efficacy of this treatment was attributed to col-
lagenase inhibition. The effect of doxycycline and
other TCs on the gelatinases (MMP-2 and -9) is less
well defined.
In the current report, we used gelatin zymography
and Western blot analysis to systematically assess pro-
tease activity in gingival biopsy samples. Specifically,
the objectives of this study were to: 1) determine
whether the levels of activated MMP-2 and MMP-9 dif-
fered in diseased versus healthy tissue; 2) assess the
effect of pH on protease activity; and 3) evaluate the
effect of tetracyclines on in situ protease activity.
MATERIALS AND METHODS
Chemicals
ADA (N-[2-acetamido]-2-iminodiacetic acid), BBI
(Bowman-Birk inhibitor), CAPS (3-[cyclohexylamino]-
l-propanesulfonic acid), DFP (diisopropylfluorophos-
phate), TRIS (Tris[hydroxymethyl]aminomethane]),
1,10-phenanthroline and gelatin were obtained from
Sigma Chemical Company (St. Louis, Missouri). Rab-
bit anti-MMP-2 (gelatinase A) polyclonal antibodies
were obtained from Chemicon (Temecula, California),
and rabbit anti-MMP-9 (gelatinase B) polyclonal anti-
bodies were generously provided by Dr. Joel Rosen-
bloom (University of Pennsylvania).
Tissue Samples
Gingival tissue samples were obtained from three
sources: 1) the Graduate Periodontics Clinic, Univer-
sity of Pennsylvania School of Dental Medicine; 2) the
Department of Oral and Maxillofacial Surgery and Hos-
pital Dentistry, Hospital of the University of Pennsyl-
vania; and 3) Dental Clinic, Veterans Administration
Hospital, Philadelphia, Pennsylvania. All subjects
underwent scaling and root planing in 4 quadrants
prior to periodontal surgery. Patients scheduled to have
gingival tissue removed during pocket elimination
surgery for treatment of chronic adult periodontitis
(probing depths 5 to 9 mm) served as the source of
diseased tissues. These patients exhibited mild gingi-
val inflammation and erythema with localized bleeding
on probing. None of the sites in the surgical areas was
suppurating. Healthy, clinically non-inflamed tissues
were obtained from a group of patients without peri-
odontal disease, who were undergoing crown length-
ening or soft tissue grafting procedures. Each subject
provided a single tissue sample. The sample cohort
consisted of 8 clinically healthy and 32 diseased sam-
ples from a total of 40 subjects. The study was
approved by the Institutional Review Board of the Uni-
versity of Pennsylvania. Informed consent was obtained
from each patient at the time of periodontal surgery.
Following surgery, excised tissue specimens were
immediately placed on ice and subsequently frozen
(−80°C). To prepare tissue extracts, samples were
thawed on ice, homogenized in PBS, and centrifuged
(10,000g × 10 minutes, 4°C). Protein concentration in
the extracts ranged from 2 to 15 mg/ml as determined
by a reagent# using bovine serum albumin (BSA) as
standard. For storage, the supernatants were diluted
with an equal volume of glycerol and stored at −20°C.
We have found that most proteases are stable for sev-
eral months under these conditions.
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# BCA Protein Assay Reagent, Pierce, Rockford, IL.
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Protease Assays
Protease activity was assessed on gelatin zymograms.
Twelve percent (12%) polyacrylamide gels (0.75 mm
thickness) were cast19 containing 0.15% gelatin as
substrate.20,21 Samples were applied to the gels under
non-reducing conditions without heating. The gels were
run, soaked in 200 ml of 2% Triton X-100 in distilled
water on a gyratory shaker (0.5 hours, 20°C), and
incubated in developing buffer (50 mM Tris [pH 8.0],
1 mM CaCl2), unless otherwise indicated, for 15 hours
at 37°C. For visualization, the gels were stained with
Coomassie blue. Protease activity shows up as clear
bands (indicative of cleavage of the gelatin substrate)
on a blue background.
For inhibition studies, zymograms were incubated in
reaction buffer containing specific protease inhibitors:
DFP (1 mM), EDTA (5 mM), BBI (10 µg/ml), phenyl-
methyl sulfonyl fluoride (PMFS) (50 µM) or tetracy-
clines (0.1 and 0.25 mM). To determine protease activ-
ity as a function of pH, samples were run on zymo-
grams and subsequently incubated in the appropriate
buffer (50 mM citrate-phosphate buffer [pH 5], 50 mM
ADA buffer [pH 6 and 7], 50 mM TRIS [pH 8 and 9] or
50 mM CAPS [pH 10]), containing 1 mM CaCl2. All
zymograms presented are representative results ob-
tained in the course of these studies.
Western Immunoblots
Tissue extracts were run on SDS-polyacrylamide gels
and transferred to nitrocellulose membranes. The
membranes were subsequently blocked in tris-buffered
saline (TBS) (50 mM Tris [pH 7.5], 150 mM NaCl)
containing 5% powdered milk and 1% BSA for 30 min-
utes, and then incubated with polyclonal anti-MMP-2
or anti-MMP-9 antibodies (prepared in rabbits) (diluted
11,000 in TBS/1% BSA) for 2 hours at 37°C.22 The
use of the anti-MMP-9 antibody has been described pre-
viously.23 The membrane was washed and incubated
with a horseradish peroxidase (HRP)-conjugated goat
anti-rabbit secondary antibody (diluted 110,000 in TBS
containing 20 µl normal goat serum/ml) for 30 min-
utes at room temperature. Bound antibody was detected
by chemiluminescence using a substrate system.**
RESULTS
The goal of this study was to investigate protease activ-
ity in human gingival tissue using gelatin zymography
and Western blotting analysis. In order to evaluate
assay sensitivity, defined amounts of trypsin were run
on a zymogram containing gelatin as substrate. Using
this approach, 1 ng of trypsin was readily detected;
gelatin cleavage was directly proportional to the
amount of protease loaded (Fig. 1). This observation
enabled us to estimate the relative amounts of pro-
tease activity in gingival tissue and to compare the
levels of enzymatic activity in healthy versus diseased
355
** SuperSignal CL-HRP, Pierce.
Figure 1.
Zymogram sensitivity. Increasing amounts of trypsin were run on a
12% polyacrylamide gel containing gelatin as substrate.The gel was
incubated in 50 mM Tris (pH 8.0), 1 mM CaCl2 (4 hours, 37°C) and
stained with Coomassie blue.The amount of gelatin cleavage (clear
areas on the gel), indicative of protease activity, was determined by
densitometry. Enzymatic activity was determined as the relative
protease activity compared to that observed with 50 ng of trypsin
(equivalent to 100 arbitrary units). Inset: Gelatin zymogram; lanes 1
through 6 contain 0 to 50 ng of trypsin. Note that 1 ng of trypsin is
readily detectable in this system.
Figure 2.
Protease activity in periodontal tissue. Extracts were prepared from
gingival tissue and analyzed on gelatin zymograms.The zymogram was
developed at pH 8 and stained. Lanes 1 through 4 contained 30 µg
protein from each sample (P, tissue obtained from periodontitis
patients; H, healthy tissue).The numbers on the left indicate molecular
mass in kDa. Note that diseased tissues have higher levels of protease
activity compared with healthy tissue.
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specimens. For analysis, equivalent amounts of pro-
tein from each sample were run on zymograms and
incubated in developing buffer (50 mM Tris [pH 8], 1
mM CaCl2). Under these conditions, both the latent
and active forms of MMPs are detected. Elevated lev-
els of protease activity with masses of approximately
60 to 90 kDa were consistently observed in samples
from patients with periodontal disease (Fig. 2). In the
course of these studies, we found the pattern of pro-
tease activity present in a particular sample to be
highly reproducible.
For initial characterization, we evaluated the ability
of proteases present in our samples to bind gelatin.
Tissue extracts were incubated with gelatin-sepharose,
the resin was washed, and bound proteins were eluted
and analyzed on gelatin zymograms. Proteases of
approximately 92, 72, and 64 kDa bound gelatin
(Fig. 3). The sizes of these proteins are consistent with
those of latent MMP-9 and latent and active MMP-2,
respectively. Further, MMP-2 and MMP-9 have a
fibronectin-like domain that enables them to bind
gelatin,24 indicating that proteins present in gingival
samples share characteristics with these proteases.
Protease identity was confirmed on Western blots.
Antibodies to MMP-2 cross-reacted with a 72 kDa
protein present in all tissue samples, indicating that
the latent form of MMP-2 is expressed in normal and
inflamed gingival tissue (Fig. 4). Several diseased
samples also expressed a 64 kDa protein that cross-
reacted with anti-MMP-2 antibodies. Since latent MMP-
2 loses a nearly 10 kDa fragment from the N-termi-
nus upon activation,24,25 the size of this protein is
consistent with the presence of active MMP-2 in
inflamed tissue. Additionally, anti-MMP-9 antibodies
cross-reacted with proteins in all samples examined
(data not shown). However, only the latent
(92 kDa) form of this enzyme was present
in normal and diseased tissue specimens.
In the next series of experiments, we deter-
mined the effect of specific protease inhibitors
on gelatin cleavage. For these studies, zymo-
grams were run and subsequently incubated
in developing buffer in the absence or pres-
ence of specific protease inhibitors. When
incubated in the presence of EDTA (Fig. 5)
or 1,10-phenanthroline (data not shown), the
92, 72, and 64 kDa proteases present in dis-
eased tissue samples were inhibited, con-
firming that they are metalloproteinases. The
sizes of these enzymes correspond to those
of latent MMP-9 (92 kDa) and latent and
active forms of MMP-2 (72 and 64 kDa,
respectively), supporting the results obtained
on Western blots. However, a protease of nearly 75
kDa was not affected by metal chelators (Fig. 5) and
was consistently present at higher levels in inflamed
versus healthy tissue. This activity was completely
inhibited when the zymograms were incubated with
EDTA and DFP (a potent inhibitor of serine pro-
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Figure 3.
Gelatin binding of protease activity. An extract prepared from inflamed
gingiva was incubated with gelatin-sepharose, the resin was washed,
and bound proteins were eluted with SDS-gel loading buffer and run on
a gelatin zymogram. Lane 1, input extract; lane 2, proteases binding to
gelatin-sepharose. Note that proteases of 92, 72, and 64 kDa bind
to immobilized gelatin. Numbers on the left represent molecular mass
in kDa.
Figure 4.
Western analysis of samples for MMP-2. Cell extracts (50 µg protein/lane) were run
on SDS-polyacrylamide gels and transferred to nitrocellulose membranes.The
membranes were incubated with antibodies to MMP-2. For some samples, extracts
were incubated with gelatin sepharose; bound proteins were extracted and run on the
gel (lanes 8 through 10). Lanes designated D and H represent extracts prepared
from diseased and healthy tissue, respectively. Note the presence of latent (arrow on
right) and active MMP-2 in diseased tissue samples. Numbers on the left indicate
molecular mass in kDa.
9082_IPC_AAP_553120  4/8/00  10:33 AM  Page 356
J Periodontol • March 2000 Korostoff, Wang, Sarment, Stewart, Feldman, Billings
teases26) or EDTA and BBI (an 8 kDa soybean-derived
inhibitor of trypsin and chymotrypsin;27 data not
shown). In contrast, N-ethylmaleimide (NEM) and pep-
statin, inhibitors of thiol and acid proteases, respec-
tively, had no effect on enzyme activity associated with
the 75 kDa protein. These results demonstrate that
the EDTA-resistant bands are serine proteases.
Tetracycline and its derivatives have been shown to
inhibit collagenase activity and prevent periodontal
attachment loss when administered at low doses.15-18,28
Experiments were performed to assess the effect of
these compounds on protease activity present in our
tissue samples. Tissue extracts were run on zymo-
grams and subsequently incubated in developing buffer
containing tetracycline, doxycycline, or minocycline.
Each antibiotic was tested at concentrations of 0.1 and
0.25 mM.29 All three compounds inhibited gelatin cleav-
age by MMP-2 and MMP-9 (Fig. 6). Doxycycline and
minocycline were more effective at inhibiting the activ-
ity of these proteases when compared to tetracycline.
To assess the effect of pH on protease activity, gin-
gival extracts were run on zymograms and subse-
quently incubated in buffers of increasing pH (6 to
10). Maximal cleavage of gelatin, indicative of pro-
tease activity, was observed at pH 8 (Fig. 7). Inter-
estingly, a protease activity (molecular mass 40 kDa)
was present when the zymograms were incubated under
more acidic conditions (pH 6, Fig. 7). This protease was
expressed in the majority of diseased gingival tissue
(90%) but was not detected in healthy tissue extracts
(0/8 samples). This protease was inhibited by PMSF,
but not by EDTA, NEM, or pepstatin (Fig. 8), sug-
gesting that the 40 kDa enzyme is a serine protease.
DISCUSSION
In this study, we demonstrate increased protease activ-
ity in diseased gingival tissue. Several lines of evi-
dence indicate that two of these proteases are MMP-
2 and MMP-9: 1) the sizes of these proteases on the
zymograms were consistent with their known masses;
2) they efficiently degraded gelatin and bound to
gelatin agarose; 3) their activity was inhibited by
EDTA and 1,10-phenanthroline; and 4) they reacted
with anti-MMP-2 and anti-MMP-9 antibodies on West-
ern blots.
MMPs are secreted as latent (inactive) enzymes
and, upon conversion into their active forms, lose a
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Figure 5.
Effect of inhibitors on protease activity.Tissue extracts were run on
gelatin zymograms.The zymograms were incubated in developing
buffer (pH 8) containing no inhibitor (lanes 1 through 3), DFP (serine
protease inhibitor, lanes 4 through 6), EDTA (an inhibitor of
metalloproteinases, lanes 7 through 9) or DFP and EDTA (lanes 10
through 12). Lanes 1, 4, 7, and 10 contain extracts of healthy tissue;
remaining lanes contain diseased tissue extracts. Numbers on the left
indicate molecular mass in kDa. Figure 6.
Effect of tetracyclines on protease activity. Inflamed tissue extracts
were run on gelatin zymograms.After electrophoresis, the zymograms
were incubated in reaction buffer (pH 8) in the absence (lanes 1 and
2) or presence of 0.1 or 0.25 mM tetracycline (lanes 3 and 4,
respectively), 0.1 or 0.25 mM doxycycline (lanes 5 and 6, respectively),
or 0.1 or 0.25 mM minocycline (lanes 7 and 8, respectively). Note that
relative to tetracycline, both doxycycline and minocycline are more
efficient at inhibiting protease activity. Numbers on the left indicate
molecular mass in kDa.
Figure 7.
Protease activity as a function of pH. Tissue extracts were run on a
gelatin zymogram and incubated at 37°C in buffers of: pH 6 (lanes 1
through 3), pH 7 (lanes 4 through 6), pH 8 (lanes 7 through 9), pH 9
(lanes 10 through12), and pH 10 (lanes 13 through 15). Lanes 1, 4, 7,
10, and 13 show extracts prepared from healthy tissues, while the
remaining lanes contain diseased tissue extracts. Note the presence of
a 40 kDa protease at pH 6 in lanes 2 and 3 (containing extracts
prepared from diseased tissues). Numbers on the left indicate
molecular mass in kDa.
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10 kDa fragment from the N-terminal region of the
protein.24,25 Latent forms of MMP-2 and MMP-9 were
detected in all tissue samples on gelatin zymograms
and Western blots. We consistently observed higher
levels of latent MMP-2 and MMP-9 in diseased tissues.
While it has been reported previously that increased
levels of MMP-2 and MMP-9 are observed in peri-
odontitis patients and that latent MMP-9 (92 kDa) is
the major gelatinase activity in oral GCF and
saliva,5,7-9,11,12 the presence of the active forms of
these proteases has not been extensively examined.
In the current investigation, we consistently observed
a protease of 64 kDa on the gelatin zymograms in
all diseased tissue samples (Figs. 2 and 3). This pro-
tein also cross-reacted with anti-MMP-2 antibodies,
strongly indicating it is the activated form of MMP-
2. We believe this is the first report showing acti-
vated MMP-2 in diseased periodontal tissue. Our
results are in contrast to those of Sorsa et al.29 who
reported little immunoreactivity with antibodies to
MMP-2 in inflamed gingival tissues. This could be a
reflection of differences in the clinical status of the
patients studied. Alternatively, the use of a com-
mercially available MMP-2–specific antibody may
have afforded us greater sensitivity on our Western
blots. Finally, it is possible that our results were due
to protease activation that ocurred during in vitro tis-
sue processing. However, two points argue against
this. First, we found no evidence of MMP-9 activa-
tion in diseased tissues. If activation were an artifact
of tissue handling, we would expect to have detected
other activated MMPs as well. Second, we did not
observe changes in MMP-2 status when the same
tissue was analyzed at different times. We therefore
consider our results to be an accurate reflection of
MMP status in situ. Since MMP-2 is derived from
fibroblasts and macrophages, our data suggest that
metaIloproteinases of non-neutrophil origin are also
involved in tissue destruction during the progression
of periodontitis.
Tetracycline derivatives are currently being utilized
to treat patients with advanced periodontal disease.28
In addition to their bacteriostatic effects, these com-
pounds have been shown to inhibit collagenase activ-
ity.15,16 However, their effect on MMP-2 and MMP-9 in
human gingival tissue has not been fully evaluated. In
this study we found that tetracycline, doxycycline, and
minocycline inhibited MMP-2 and MMP-9. These com-
pounds are thought to inhibit MMP activity by chelat-
ing metal ions; they may also block conversion of
latent proteases into their mature active forms.11,28
Complete inhibition of MMP-2 was observed with
100µM doxycycline and minocycline. These results
indicate that the clinical efficacy of tetracycline deriv-
atives may be due in part to their ability to block the
conversion of latent MMP-2 into its active form and
directly inhibit its proteolytic activity.
In addition to elevated metalloproteinase activity in
inflamed tissue, other protease activities were also
increased. These included a 75 kDa protease which is
sensitive to DFP and BBI, indicating that it is a serine
protease. Interestingly, when the zymograms were incu-
bated at pH 6, a protease of approximately 40 kDa was
observed. Expression of this activity was restricted to
diseased gingival tissues. To our knowledge, detection
of proteases with these properties has not been
reported in inflamed periodontal tissues. Based on their
size, both the 40 and 75 kDa enzymes appear to be
distinct from elastase (30 kDa) and cathepsin G (30
kDa), two neutrophil-derived serine proteases.30
We also observed a pronounced effect of pH on
overall protease activity (Fig. 7). Not surprisingly,
MMPs were clearly active at neutral and alkaline pH
but not at acidic pH. However, we did observe a low
molecular weight activity at pH 6 that was inhibited
by PMSF, suggesting that this enzyme is a serine pro-
tease. This activity was detected only in extracts pre-
pared from inflamed tissues. It is tempting to specu-
late that in vivo protease activity will be influenced by
local differences in pH and, further, that pH may have
a major effect on the distribution of active proteases
in intact tissue. For example, tissue pH will likely vary
depending upon metabolic and redox state, degree of
inflammation, blood flow, and other factors.31,32 The
results of our analysis suggest that MMP activity will
be highest under conditions where tissue pH is neu-
tral or alkaline, while other proteases would be
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Figure 8.
Effects of inhibitors on 40 kDa protease activity. Inflamed tissue
extracts from two periodontitis patients were run on gelatin
zymograms.After electrophoresis, the zymograms were incubated in
reaction buffer at pH 8 without inhibitors or at pH 6 in the absence or
presence of 5 mM EDTA or 1mM PMSF. Note that the 40 kDA
protease is active at pH 6 and is inhibited by PMSF but not by EDTA.
Numbers on the left indicate molecular mass in kDa.
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expected to be active at more acidic pH, which could
potentially develop under inflammatory conditions.
The 40 kDa protease described in this report (Fig. 8)
may be active in such areas.
The results obtained in the current study support
the thesis that host-derived proteases are directly
involved in the tissue destruction observed in peri-
odontitis. Specifically, we have observed increased lev-
els of active MMP-2 and a unique 40 kDa protease in
tissue samples derived from chronic periodontitis
patients. Our observations suggest that these enzymes
may play a more important role in the pathogenesis
of periodontal disease than previously thought. Current
clinical research indicates that protease inhibitors may
have significant potential as adjuncts for treating a
variety of intraoral diseases including periodontal dis-
ease11,29 and oral cancer.30,33 Future studies will be
directed at: 1) purification and characterization of the
40 kDa serine protease and 2) identification of com-
pounds that selectively inhibit MMP-2 and the serine
protease to evaluate their efficacy in the treatment of
periodontal disease.
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